Structural biology of carbohydrate xenoantigens

Elizabeth Yuriev, Mark James Agostino, W Farrugia, Dale Christiansen, Mauro Sergio Sandrin, Paul Allen Ramsland

Research output: Contribution to journalArticleResearchpeer-review

18 Citations (Scopus)

Abstract

Transplantation of organs across species (xenotransplantation) is being considered to overcome the shortage of human donor organs. However, unmodified pig organs undergo an anti body-mediated hyperacute rejection that is brought about by the presence of natural antibodies to Gal alpha(1,3)Gal, which is the major carbohydrate xenoantigen. Genetic modification of pig organs to remove most of the Gal alpha(1,3)Gal epitopes has been achieved, but the human immune system may still recognize residual lipid-linked Gal alpha(1,3) Gal carbohydrates, new (cryptic) carbohydrates or additional non-Gal alpha(1,3) Gal carbohydrate xenoantigens. The structural basis for lectin and antibody recognition of Gal alpha(1,3)Gal carbohydrates is starting to be understood and is discussed in this review. Antibody binding to Gal alpha(1,3)Gal carbohydrates is predicted to primarily involve end-on insertion of the terminal alpha Gal residue, but it is possible that groove-type binding can occur, as for some lectins. It is likely that similar antibody and lectin recognition will occur with other non-Gal alpha(1,3)Gal xenoantigens, which potentially represent new barriers for pig-to-human xenotransplantation.
Original languageEnglish
Pages (from-to)1017 - 1029
Number of pages13
JournalExpert Opinion on Biological Therapy
Volume9
Issue number8
DOIs
Publication statusPublished - 2009

Cite this

Yuriev, Elizabeth ; Agostino, Mark James ; Farrugia, W ; Christiansen, Dale ; Sandrin, Mauro Sergio ; Ramsland, Paul Allen. / Structural biology of carbohydrate xenoantigens. In: Expert Opinion on Biological Therapy. 2009 ; Vol. 9, No. 8. pp. 1017 - 1029.
@article{32c772e4c6d44317a70c6a2f9be987ba,
title = "Structural biology of carbohydrate xenoantigens",
abstract = "Transplantation of organs across species (xenotransplantation) is being considered to overcome the shortage of human donor organs. However, unmodified pig organs undergo an anti body-mediated hyperacute rejection that is brought about by the presence of natural antibodies to Gal alpha(1,3)Gal, which is the major carbohydrate xenoantigen. Genetic modification of pig organs to remove most of the Gal alpha(1,3)Gal epitopes has been achieved, but the human immune system may still recognize residual lipid-linked Gal alpha(1,3) Gal carbohydrates, new (cryptic) carbohydrates or additional non-Gal alpha(1,3) Gal carbohydrate xenoantigens. The structural basis for lectin and antibody recognition of Gal alpha(1,3)Gal carbohydrates is starting to be understood and is discussed in this review. Antibody binding to Gal alpha(1,3)Gal carbohydrates is predicted to primarily involve end-on insertion of the terminal alpha Gal residue, but it is possible that groove-type binding can occur, as for some lectins. It is likely that similar antibody and lectin recognition will occur with other non-Gal alpha(1,3)Gal xenoantigens, which potentially represent new barriers for pig-to-human xenotransplantation.",
author = "Elizabeth Yuriev and Agostino, {Mark James} and W Farrugia and Dale Christiansen and Sandrin, {Mauro Sergio} and Ramsland, {Paul Allen}",
year = "2009",
doi = "10.1517/14712590903066703",
language = "English",
volume = "9",
pages = "1017 -- 1029",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
publisher = "Taylor & Francis",
number = "8",

}

Yuriev, E, Agostino, MJ, Farrugia, W, Christiansen, D, Sandrin, MS & Ramsland, PA 2009, 'Structural biology of carbohydrate xenoantigens', Expert Opinion on Biological Therapy, vol. 9, no. 8, pp. 1017 - 1029. https://doi.org/10.1517/14712590903066703

Structural biology of carbohydrate xenoantigens. / Yuriev, Elizabeth; Agostino, Mark James; Farrugia, W; Christiansen, Dale; Sandrin, Mauro Sergio; Ramsland, Paul Allen.

In: Expert Opinion on Biological Therapy, Vol. 9, No. 8, 2009, p. 1017 - 1029.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Structural biology of carbohydrate xenoantigens

AU - Yuriev, Elizabeth

AU - Agostino, Mark James

AU - Farrugia, W

AU - Christiansen, Dale

AU - Sandrin, Mauro Sergio

AU - Ramsland, Paul Allen

PY - 2009

Y1 - 2009

N2 - Transplantation of organs across species (xenotransplantation) is being considered to overcome the shortage of human donor organs. However, unmodified pig organs undergo an anti body-mediated hyperacute rejection that is brought about by the presence of natural antibodies to Gal alpha(1,3)Gal, which is the major carbohydrate xenoantigen. Genetic modification of pig organs to remove most of the Gal alpha(1,3)Gal epitopes has been achieved, but the human immune system may still recognize residual lipid-linked Gal alpha(1,3) Gal carbohydrates, new (cryptic) carbohydrates or additional non-Gal alpha(1,3) Gal carbohydrate xenoantigens. The structural basis for lectin and antibody recognition of Gal alpha(1,3)Gal carbohydrates is starting to be understood and is discussed in this review. Antibody binding to Gal alpha(1,3)Gal carbohydrates is predicted to primarily involve end-on insertion of the terminal alpha Gal residue, but it is possible that groove-type binding can occur, as for some lectins. It is likely that similar antibody and lectin recognition will occur with other non-Gal alpha(1,3)Gal xenoantigens, which potentially represent new barriers for pig-to-human xenotransplantation.

AB - Transplantation of organs across species (xenotransplantation) is being considered to overcome the shortage of human donor organs. However, unmodified pig organs undergo an anti body-mediated hyperacute rejection that is brought about by the presence of natural antibodies to Gal alpha(1,3)Gal, which is the major carbohydrate xenoantigen. Genetic modification of pig organs to remove most of the Gal alpha(1,3)Gal epitopes has been achieved, but the human immune system may still recognize residual lipid-linked Gal alpha(1,3) Gal carbohydrates, new (cryptic) carbohydrates or additional non-Gal alpha(1,3) Gal carbohydrate xenoantigens. The structural basis for lectin and antibody recognition of Gal alpha(1,3)Gal carbohydrates is starting to be understood and is discussed in this review. Antibody binding to Gal alpha(1,3)Gal carbohydrates is predicted to primarily involve end-on insertion of the terminal alpha Gal residue, but it is possible that groove-type binding can occur, as for some lectins. It is likely that similar antibody and lectin recognition will occur with other non-Gal alpha(1,3)Gal xenoantigens, which potentially represent new barriers for pig-to-human xenotransplantation.

UR - http://informahealthcare.com/doi/abs/10.1517/14712590903066703

U2 - 10.1517/14712590903066703

DO - 10.1517/14712590903066703

M3 - Article

VL - 9

SP - 1017

EP - 1029

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

SN - 1471-2598

IS - 8

ER -